Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist |
Lee, Young-Ran
(College of Pharmacy, Chungbuk National University)
Lee, Young-Hee (College of Pharmacy, Chungbuk National University) Kim, Ki-Hyang (College of Pharmacy, Chungbuk National University) Im, Sun-A (College of Pharmacy, Chungbuk National University) Lee, Chong-Kil (College of Pharmacy, Chungbuk National University) |
1 | Van Der Bruggen. P., Y. Zhang, P. Chaux, V. Stroobant, C. Panichelli, E. S. Schultz, J. Chapiro, B. J. Van Den Eynde, F. Brasseur, and T. Boon. 2002. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol. Rev. 188: 51-64. DOI |
2 | Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961-965. DOI |
3 | Harding, C. V. 1995. Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol. 5: 105-109 DOI |
4 | Sigal, L. J., S. Crotty, R. Andino, K. L. Rock. 1999. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398: 77-80. DOI |
5 | Heath, W. R. and F. R. Carbone. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19: 47-64. DOI |
6 | Carbone, F. R., C. Kurts, S. R. Bennett, J. F. Miller, and W. R. Heath. 1998. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol. Today 19: 368-373. DOI |
7 | Shen, H., A. L. Ackerman, V. Cody, A. Giodini, E. R. Hinson, P. Cresswell, R. L. Edelson, W. M. Saltzman, and D. J. Hanlon. 2006. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117: 78-88. DOI |
8 | Gerelchuluun, T., Y. H. Lee, Y. R. Lee, S. A. Im, Song S, J. S. Park, K. Han, K. Kim, and C. K. Lee. 2007. Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D,L-lactide-co-glycolide), via an alternate class I MHC processing pathway. Arch. Pharm. Res. 30: 1440-1446. DOI |
9 | Lee, Y. R., Y. H. Lee, S. A. Im, I. H. Yang, G. W. Ahn, K. Kim, and C. K. Lee. 2010. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen. Arch. Pharm. Res. 33: 1859-1866. DOI |
10 | Schliehe, C., C. Redaelli, S. Engelhardt, M. Fehlings, M. Mueller, N. van Rooijen, M. Thiry, K. Hildner, H. Weller, and M. Groettrup. 2011. CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphereencapsulated antigen in vivo. J. Immunol. 187: 2112-2121. DOI |
11 | Newman, K. D., D. L. Sosnowski, G. S. Kwon, and J. Samuel. 1998. Delivery of MUC1 mucin peptide by Poly (d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses. J. Pharm. Sci. 87: 1421-1427. DOI |
12 | Venkataprasad, N., A. G. Coombes, M. Singh, M. Rohde, K. Wilkinson, F. Hudecz, S. S. Davis, and H. M. Vordermeier. 1999. Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers. Vaccine 17: 1814-1819. DOI |
13 | Lee, Y. R., I. H. Yang, Y. H. Lee, S. A. Im, S. Song, H. Li, K. Han, K. Kim, S. K. Eo, and C. K. Lee. 2005. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 105: 3951-3955. DOI |
14 | Panyam, J. and V. Labhasetwar. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55: 329-347. DOI |
15 | Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785. DOI |
16 | Panyam, J. and V. Labhasetwar. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55: 329-347. DOI |
17 | Lee, Y. R., Y. H. Lee, S. A. Im, K. Kim, and C. K. Lee. 2011. Formulation and characterization of antigen-loaded PLGA nanoparticles for efficient cross-priming of the antigen. Immune Netw. 11: 163-168. DOI |
18 | Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findlay, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361: 359-362. DOI |
19 | Elamanchili, P., M. Diwan, M, Cao, and J. Samuel. 2004. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22: 2406-2412. DOI |
20 | Lee, Y. H., Y. R. Lee, K. H. Kim, S. A. Im, S. Song, M. K. Lee, Y. Kim, J. T. Hong, K. Kim, and C. K. Lee. 2011. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells. Int. Immunopharmacol. 11: 985-991. DOI |
![]() |